I Love Lund (LOVE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Investment pace increased in Q2 2024, with SEK 1.7M allocated mainly to Beammwave, Sensative, and Life Finder; no new investments or divestments occurred.
Result after financial items improved to -1.0 MSEK in Q2 2024 from -3.0 MSEK in Q2 2023, mainly due to reduced write-downs and a reversal in Life Finder.
Portfolio consists of about 50 mainly unlisted, early-stage, innovative companies, diversified across sectors and focused on the Lund region.
Cash position remains strong, with SEK 3.9M at period end and no long-term interest-bearing debt.
Several well-attended shareholder events were held, including a visit to Alfa Laval.
Financial highlights
Net sales for both Q2 and H1 2024 were SEK 0 (unchanged year-over-year).
Operating result for Q2 2024 was -811 TSEK (vs. -686 TSEK Q2 2023); H1 2024 was -1.5 MSEK (vs. -1.3 MSEK H1 2023).
Financial items (mainly write-downs) for Q2 2024 were -150 TSEK (vs. -2.3 MSEK Q2 2023); H1 2024 was -1.5 MSEK (vs. -4.1 MSEK H1 2023).
Result after financial items for H1 2024 was -3.0 MSEK (vs. -5.4 MSEK H1 2023); EPS for H1 2024 was -7.8 SEK (vs. -14.2 SEK H1 2023).
Investments in portfolio companies totaled SEK 2.9M in H1 2024 (vs. SEK 2.3M H1 2023).
Outlook and guidance
Management sees a cautiously optimistic market sentiment, with increased risk appetite driven by lower inflation and interest rate trends.
No formal forecast is provided.
Pipeline of investment opportunities is considered strong, with a target of 2–4% cash holding in the near term.
Latest events from I Love Lund
- Full-year net result improved to SEK -4.8m, with a diversified, innovation-focused portfolio.LOVE
Q4 202523 Jan 2026 - Stable operating loss, improved net result, and strong equity amid active portfolio management.LOVE
Q3 202524 Oct 2025 - NAV and book value rose in Q2, driven by portfolio gains and new investment in Lead Biologics.LOVE
Q2 202525 Jul 2025 - Net loss driven by write-downs, but strong equity and new capital raised for future investments.LOVE
Q3 202413 Jun 2025 - Negative Q1 result driven by accounting change; local investment focus and strong equity remain.LOVE
Q1 20256 Jun 2025 - Losses increased on write-downs, but solvency and liquidity remain robust.LOVE
Q4 20246 Jun 2025